Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Days Sales Outstanding : 50.73 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Jagsonpal Pharmaceuticals Days Sales Outstanding?

Jagsonpal Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was ₹263 Mil. Jagsonpal Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹472 Mil. Hence, Jagsonpal Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 50.73.

The historical rank and industry rank for Jagsonpal Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

NSE:JAGSNPHARM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.69 Med: 71.68 Max: 119.04
Current: 38.48

During the past 13 years, Jagsonpal Pharmaceuticals's highest Days Sales Outstanding was 119.04. The lowest was 23.69. And the median was 71.68.

NSE:JAGSNPHARM's Days Sales Outstanding is ranked better than
81.8% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.34 vs NSE:JAGSNPHARM: 38.48

Jagsonpal Pharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (34.37) to Dec. 2023 (50.73).

Jagsonpal Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Jagsonpal Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jagsonpal Pharmaceuticals Days Sales Outstanding Chart

Jagsonpal Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

50.22

48.57

33.13

23.69

28.10

Jagsonpal Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															34.37	34.35	31.66	41.44	50.73

Competitive Comparison of Jagsonpal Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Jagsonpal Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jagsonpal Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jagsonpal Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jagsonpal Pharmaceuticals's Days Sales Outstanding falls into.

Jagsonpal Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jagsonpal Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (155.77	+	208.72)	/	2 )	/	2367.14	*	365
=	182.245					/	2367.14	*	365
=	28.10

Jagsonpal Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (262.62	+	0)	/	1 )	/	472.34	*	365 / 4
=	262.62					/	472.34	*	365 / 4
=	50.73

Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Jagsonpal Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jagsonpal Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jagsonpal Pharmaceuticals Ltd (NSE:JAGSNPHARM) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

507789:India

Address

3rd Floor, Phase – IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015

Website

https://www.jagsonpal.com

Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company has a single reporting segment namely, the Pharmaceutical segment, and derives its revenue from the same. Its brands comprise Lycored, Maintane, Metadec, Metabol, Doxypal DR, and others.

Jagsonpal Pharmaceuticals (NSE:JAGSNPHARM) Headlines

No Headlines